The Long & Short (Term) Of The Pharmaceutical Sector
We have written many times about the challenge of weighing positive vs.negative inputs when analyzing the attractiveness of the investment climate. Often times, that applies…
We have written many times about the challenge of weighing positive vs.negative inputs when analyzing the attractiveness of the investment climate. Often times, that applies…
The Baltic Dry Index has doubled from its February all-time lows. On January 30, we wrote a post on the Baltic Dry Index (BDI), a composite…
In case you missed it, we posted a piece yesterday on the STOXX Europe 600 in which we reiterated our month-long bullish stance on European…
Most market participants have probably heard of the oft-ridiculed indicator known as the “Hindenburg Omen” (HO). If you are not familiar with it, there are several…
About a month ago, we laid out a case for another up-leg in European equities. The case was built strictly off of a technical, charting…
While the post-2009 cyclical bull market has yet to run its course, there is a clear leader in the clubhouse in the race for poster…
On Friday July 26, 2002, the film Austin Powers In Goldmember was released in theaters. While I can’t recall whether it won any Academy Awards,…
It is often said, by us and others in the investment community, that the stock market does not equal the economy. In other words, the pricing…
On Friday, we posted a chart showing a rare occurrence of 2 consecutive inside days (i.e., the range is inside of the previous day’s range)…
It was a wild week on Wall Street – and all the streets around the world that are home to various country stock exchanges. It…